Circulating tumor cells can be detected by means of flow cytometry in the blood of mice bearing i.m. Lewis lung carcinoma. This technique can be applied in the case of aneuploid tumors and does not require either concentration of nucleated cells or other processing of the blood samples. It offers the advantages of simplicity and speed and allows quantitative measurement of the number of circulating tumor cells. It can be applied to the study of the effects of drug treatment on the number of circulating tumor cells, for those drugs which do not cause alterations in the nuclear DNA content of normal diploid blood cells. The number of circulating tumor cells determined by flow cytometry is markedly reduced by treatment with ICRF-159, by dimethyltriazene DM-COOK, and also by its clinically used analog, DTIC.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Alexander, R. F., and Spriggs, A. I., 1960, The differential diagnosis of tumor cells in circulating blood. Journal of Clinical Pathology, 13, 414–424.
Barlogie, B., Gohde, W., Johnston, D. A., Smallwood, L., Schumann, J., Drewinko, B., and Freireich, E. J., 1978, Determination of ploidy and proliferative characteristics of human solid tumors by pulse cytophotometry. Cancer Research, 38, 3333–3339.
Braylan, R. C., Diamond, L. W., Powell, M. L., and Harty-Golder, B., 1980, Percentage of cells in the S phase of the cell cycle in human lymphoma determined by flow cytometry. Correlation with labeling index and patient survival. Cytometry, 1, 171–174.
Carter, R. L., 1978, General pathology of the metastasis process. Secondary Spread of Cancer, edited by R. W. Baldwin (London, Academic Press), pp. 1–52.
Colombo, T., Garattini, S., Lassiani, L., and D'Incalci, M., 1982, Activity of p-(3,3-dimethyl-l-triazeno)benzoic acid potassium salt on M 5076/73A ovarian reticular cell sarcoma of the mouse. Cancer Treatment Reports, 66, 1945–1948.
Costa, A., Mazzini, G., Del Bino, G., and Silvestrini, R., 1981, DNA content and kinetic characteristics of non-Hodgkin's lymphoma: determined by flow cytometry and autoradiography. Cytometry, 2, 104–109.
Fisher, B., and Fisher, E. R., 1967, Metastases of cancer cells. Methods in Cancer Research, edited by H. Bush (New York: Academic Press), pp. 243–286.
Fowlkes, B. J., Herman, C. J., and Cassidy, M., 1976. Flow microfluorometric system for screening gynecologic cytology specimens using propidium iodide-fluorescein isothiocyanate. Journal of Histochemistry and Cytochemistry, 24, 322–331.
Giraldi, T., Houghton, P. J., Taylor, D. M., and Nisi, C., 1978, Antimetastatic action of some triazene derivatives against the Lewis lung carcinoma in mice. Cancer Treatment Reports, 62, 721–725.
Giraldi, T., Sava, G., Cuman, R., Nisi, C., and Lassiani, L., 1981, Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-l-triazeno)benzoic acid potassium salt, (±) 1,2-di(3,5-dioxopiperazin-1-yl)propane and cyclophosphamide in mice bearing Lewis lung carcinoma. Cancer Research, 41, 2525–2528.
Grattarola, M., Zietz, S., Lessin, S., Desaive, C., and Nicolini, C., 1979, Early detection of micrometastases via flow microfluorimetry. Cancer Biochemistry Biophysics, 4, 13–18.
James, S. E., and Salsbury, A. J., 1971 Effect of (±)-1,2-bis(3,5-dioxopiperazin-1-yl)propane on tumor blood vessels and its relationship to the antimetastatic effect in the Lewis lung carcinoma. Cancer Research, 34, 839–842.
Krishan, A., 1975, Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. Journal of Cell Biology, 66, 188–193.
Lessin, S. R., Abraham, S. R., and Nicolini, C., 1982, Biophysical identification and sorting of high metastatic variants from B16 melanoma tumor. Cytometry, 2, 407–413.
Litchfield, J., and Wilcoxon, F., 1949, A simplified method of evaluating dose-effect experiments. Journal of Pharmacology and Experimental Therapeutics, 96, 99–113.
Malmgren, R. A., 1967, Studies of circulating cancer cells in cancer patients. Mechanism of Invasion in Cancer, edited by P. Denoix (Berlin: Springer-Verlag), pp. 108–117.
Melamed, M. R., Traganos, F., Sharpless, T., and Darzynkiewicz, Z., 1976, Urinary cytology automation: Preliminary studies with acridine orange stain and flow-through cytofluorometry. Investigative Urology, 13, 331–338.
Peterson, S. E., Bichel, P., and Lorentzen, M., 1978, Flow cytometric demonstration of tumor-cell subpopulations with different DNA content in human colo-rectal carcinoma. European Journal Cancer, 15, 383–387.
Riccardi, A., Mazzini, G., Montecucco, C., Cresci, R., Traversi, E., Berzuini, C., and Ascari, E., 1982, Sequential Vincristine, Arabinosylcytosine and Adriamycin in acute leukemia: cytologic and cytokinetic studies. Cytometry, 3, 104–109.
Sacchi, A., Corsi, A., Caputo, M., and Zupi, G., 1979, In vitro and in vivo selection of two Lewis lung carcinoma cell lines. Tumori, 65, 657–664.
Salsbury, A. J., 1975, The significance of the circulating cancer cell. Cancer Treatment Reviews, 2, 55–72.
Salsbury, A. J., Burrage, K., and Hellmann, K., 1974, Histological analysis of the antimetastatic effect of (±)1,2-bis(3,5-dioxopiperazin-1-yl)propane. Cancer Research, 34, 843–849.
Sava, G., Giraldi, T., Lassiana, L., and Nisi, C., 1984, Antimetastatic action and hematological toxicity of p-(3,3-dimethyl-l-triazeno)-benzoic acid potassium salt and 5-(3,3-dimethyl-l-triazeno)-imidazole-4-carboxamide used as prophylactic adjuvants to surgical tumor removal in mice bearing B16 melanoma. Cancer Research, 44, 64–68.
Sava, G., Giraldi, T., Nisl, C., and Bertoli, G., 1982, Prophylactic antimetastatic treatment with aryldimethyltriazenes as adjuvants to surgical tumor removal in mice bearing Lewis lung carcinoma. Cancer Treatment Reports, 66, 115–120.
Shirakawa, S., and Frei, E., 1970, Comparative effects of the antitumor agents 5(dimethyltriazeno)-imadazole-4-carboxamide and 1,3-bis(2-chloroethyl)-1-nitrosourea on cell cycle of L1210 leukemia cells in vivo. Cancer Research, 30, 2173–2179.
Sixth New Drug Seminar on DTIC, 1976, edited by S. K. Carter, Cancer Treatment Reports, 62, 721–725.
Starace, G., Badaracco, G., Greco, C., Sacchi, A., and Zupi, G., 1982, DNA content distribution of in vivo and in vitro lines of Lewis lung carcinoma. European Journal of Cancer and Clinical Oncology, 18, 973–978.
Taylor, I. W., and Bleehen, N. M., 1978, Razoxane induced polyploidy. British Journal of Cancer, 38, 143–147.
Tribukait, B., Gustafson, H., and Esposti, P., 1979, Ploidy and proliferation in human bladder tumors as measured by flow cytofluorometric DNA analysis and its relations to histopathology and cytology. Cancer, 43, 1742–1751.
Zupi, G., Mauro, F., and Sacchi, A., 1980, Cloning in vitro and in vivo of Lewis lung carcinoma: properties and characteristics. British Journal of Cancer, 41 Suppl. IV, 309–310.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Giraldi, T., Sava, G., Cherubino, R. et al. Effects of DTIC, DM-COOK and ICRF-159 on the number of circulating Lewis lung carcinoma cells detected by flow cytometry. Clin Exp Metast 2, 151–159 (1984). https://doi.org/10.1007/BF00052415
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00052415